Valuation TAUNS Laboratories,Inc.
Stocks
197A
JP3452250008
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 491.00 JPY | +0.61% |
|
+0.61% | -3.54% |
| 05-14 | Tauns Laboratories,Inc. Provides Earnings Guidance for the Full Year Ending June 30, 2026 | CI |
| 03-30 | TAUNS Laboratories,Inc. Revises Earnings Guidance for the Year Ending June 30, 2026 | CI |
Company Valuation: TAUNS Laboratories,Inc.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Market Cap 1 | 41,000 | 52,314 | 52,314 | - |
| Change | - | 27.6% | 0% | - |
| Enterprise Value (EV) 1 | 41,114 | 60,244 | 60,308 | 61,069 |
| Change | - | 46.53% | 1.97% | 1.26% |
| P/E | 7.1x | 8.67x | 9.88x | 14.5x |
| PBR | 3x | 3.15x | 2.66x | 2.58x |
| PEG | - | 1.16x | -0.4x | -0.5x |
| Capitalization / Revenue | 2.22x | 2.96x | 3.55x | 2.72x |
| EV / Revenue | 2.23x | 3.23x | 4.09x | 3.17x |
| EV / EBITDA | 4.72x | 6.71x | 11.9x | 9.35x |
| EV / EBIT | 5.12x | 7.29x | 15.7x | 12.6x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | 21.75 | 28 | 35.28 | 28 |
| Rate of return | 5.3% | 5.2% | 7.19% | 5.7% |
| EPS 2 | 57.74 | 62.07 | 49.72 | 33.75 |
| Distribution rate | 37.7% | 45.1% | 71% | 83% |
| Net sales 1 | 18,435 | 18,628 | 14,756 | 19,252 |
| EBITDA 1 | 8,706 | 8,980 | 5,053 | 6,531 |
| EBIT 1 | 8,030 | 8,265 | 3,846 | 4,833 |
| Net income 1 | 5,774 | 6,315 | 5,201 | 3,593 |
| Net Debt 1 | 114.1 | 5,157 | 7,994 | 8,755 |
| Reference price 2 | 410.00 | 491.00 | 491.00 | 491.00 |
| Nbr of stocks (in thousands) | 100,000 | 106,546 | 106,546 | - |
| Announcement Date | 8/13/24 | 8/13/25 | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 7.63x | 3.09x | 5.97x | 5.58% | 324M | |
| -44.51x | 13.42x | -98.65x | -.--% | 17.12B | |
| 16.05x | 1.83x | 7.46x | 1.63% | 9.26B | |
| 25.81x | 4.41x | 12.41x | - | 6.72B | |
| 176.36x | 4.6x | 29.54x | -.--% | 5.05B | |
| 18.26x | 6.27x | 14.17x | 3.16% | 4.96B | |
| -39.48x | 5.86x | -48.57x | -.--% | 4.08B | |
| 19.04x | 3.34x | 10.38x | 2.05% | 3.97B | |
| 15.58x | - | - | 4.11% | 2.62B | |
| Average | 21.64x | 5.35x | -8.41x | 2.07% | 6.01B | |
| Weighted average by Cap. | 9.22x | 7.16x | -28.59x | 1.09% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 197A Stock
- Valuation TAUNS Laboratories,Inc.
Select your edition
All financial news and data tailored to specific country editions
